These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 3535769

  • 21. Ventricular antiarrhythmic effects of beta-adrenergic blocking drugs: a review of mechanism and clinical studies.
    Pratt C, Lichstein E.
    J Clin Pharmacol; 1982; 22(8-9):335-47. PubMed ID: 6127349
    [Abstract] [Full Text] [Related]

  • 22. [Rhythm troubles: when and how to treat them?].
    Jaeger M.
    Schweiz Med Wochenschr; 1981 Nov 07; 111(45):1691-3. PubMed ID: 7313634
    [Abstract] [Full Text] [Related]

  • 23. [Prevention and therapy of tachy-arrhythmias].
    Burckhardt D.
    Schweiz Rundsch Med Prax; 1985 Dec 03; 74(49):1361-5. PubMed ID: 4081446
    [No Abstract] [Full Text] [Related]

  • 24. Omega-3 in antiarrhythmic therapy : cons position.
    Borghi C, Pareo I.
    High Blood Press Cardiovasc Prev; 2012 Dec 03; 19(4):207-11. PubMed ID: 23430665
    [Abstract] [Full Text] [Related]

  • 25. Patients with malignant or potentially malignant ventricular arrhythmias: opportunities and limitations of drug therapy in prevention of sudden death.
    Bigger JT.
    J Am Coll Cardiol; 1985 Jun 03; 5(6 Suppl):23B-26B. PubMed ID: 3889110
    [Abstract] [Full Text] [Related]

  • 26. Premature ventricular contractions: Which ones require treatment?
    Lyons CJ, Han J.
    Heart Lung; 1981 Jun 03; 10(4):691-5. PubMed ID: 6909197
    [Abstract] [Full Text] [Related]

  • 27. Electrophysiologic Study versus Electrocardiographic Monitoring (ESVEM): a critical appraisal.
    Prystowsky EN.
    Control Clin Trials; 1996 Jun 03; 17(3 Suppl):28S-36S. PubMed ID: 8877265
    [Abstract] [Full Text] [Related]

  • 28. Indications for antiarrhythmic therapy: a wealth of controversy, a dearth of data.
    Woosley RL.
    Ann Intern Med; 1988 Mar 03; 108(3):450-2. PubMed ID: 3277517
    [No Abstract] [Full Text] [Related]

  • 29. Beta-adrenergic receptor blocking drugs in the treatment of cardiac arrhythmias.
    Theilen EO, Wilson WR.
    Med Clin North Am; 1968 Sep 03; 52(5):1017-29. PubMed ID: 4386418
    [No Abstract] [Full Text] [Related]

  • 30. Treatment of ventricular arrhythmias with mexiletine (Kö 1173).
    Talbot RG, Nimmo J, Julian DG, Clark RA, Neilson JM, Prescott LF.
    Lancet; 1973 Aug 25; 2(7826):399-404. PubMed ID: 4124889
    [No Abstract] [Full Text] [Related]

  • 31. Sudden cardiac death. Helping those at risk survive.
    Malacoff RF.
    Postgrad Med; 1984 Mar 25; 75(4):269-74. PubMed ID: 6701131
    [Abstract] [Full Text] [Related]

  • 32. Mexiletine (Kö 1173) in the management of ventricular dysrhythmias.
    Campbell NP, Kelly JG, Shanks RG, Chaturvedi NC, Strong JE, Pantridge JF.
    Lancet; 1973 Aug 25; 2(7826):404-7. PubMed ID: 4124890
    [No Abstract] [Full Text] [Related]

  • 33. [The problem of sudden cardiae death in coronary heart disease].
    Schröder R.
    Dtsch Med Wochenschr; 1972 Apr 07; 97(14):574-8. PubMed ID: 4112251
    [No Abstract] [Full Text] [Related]

  • 34. [Clinical evaluation of new anti-arrhythmia drugs after the CAST (Cardiac Arrhythmia Suppression Trial) study].
    Meinertz T, Zehender M, Hohnloser SH.
    Z Kardiol; 1992 Apr 07; 81 Suppl 4():145-9. PubMed ID: 1290291
    [Abstract] [Full Text] [Related]

  • 35. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.
    Cairns JA, Connolly SJ, Roberts R, Gent M.
    Lancet; 1997 Mar 08; 349(9053):675-82. PubMed ID: 9078198
    [Abstract] [Full Text] [Related]

  • 36. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS).
    Burkart F, Pfisterer M, Kiowski W, Follath F, Burckhardt D.
    J Am Coll Cardiol; 1990 Dec 08; 16(7):1711-8. PubMed ID: 2254558
    [Abstract] [Full Text] [Related]

  • 37. Assessment of arrhythmias after myocardial infarction in the post-CAST era.
    Camm AJ, Kautzner J.
    Can J Cardiol; 1996 Apr 08; 12 Suppl B():9B-19B; discussion 27B-28B. PubMed ID: 8616727
    [Abstract] [Full Text] [Related]

  • 38. Bedside management of acute myocardial infarction.
    Gazes PC, Gaddy JE.
    Am Heart J; 1979 Jun 08; 97(6):782-96. PubMed ID: 373406
    [No Abstract] [Full Text] [Related]

  • 39. Symposium on the management of ventricular dysrhythmias. Antifibrillatory versus antiectopic therapy.
    Anderson JL.
    Am J Cardiol; 1984 Jul 30; 54(2):7A-13A. PubMed ID: 6147079
    [Abstract] [Full Text] [Related]

  • 40. Measuring antiarrhythmic drug efficacy by suppression of asymptomatic ventricular arrhythmias.
    Winkle RA.
    Ann Intern Med; 1979 Sep 30; 91(3):480-2. PubMed ID: 475177
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.